Citigroup’s BioCardia BCDA Stock Holding History

Citigroup’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-833	Closed	-$1.07K	–	6081
2025 Q3	$1.07K	Buy	+833	New	+$1.63K	﹤0.01%	5616

Other funds holding BCDA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Citigroup's BCDA Position: Q4 2025 in Review

Citigroup sold out of BioCardia (BCDA) in Q4 2025, closing a stake of 833 shares — an estimated $1.07K sold.

Citigroup first reported a position in BCDA in Q3 2025 and held it in 1 quarter. The position peaked at $1.07K in Q3 2025. 20 funds tracked by Wall St. Rank hold BCDA as of Q4 2025.

Citigroup reported no remaining BioCardia position as of Q4 2025 after selling out during the quarter.
Citigroup sold 833 BioCardia shares in Q4 2025, an estimated $1.07K.
Citigroup first reported a position in BioCardia in Q3 2025 and held it in 1 quarter.
Citigroup's BioCardia position peaked at $1.07K in Q3 2025.
20 funds tracked by Wall St. Rank held BioCardia as of Q4 2025.

Based on Citigroup's 13F filing for Q4 2025, filed 13 Feb 2026.